Prognostic Factors in Primary Cutaneous B-Cell Lymphoma: The Italian Study Group for Cutaneous LymphomasPier Luigi Zinzani, Maria Grazia Bernengo, Gianandrea Baliva et al.|Journal of Clinical Oncology|2006Cited by 230
Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real‐world setting: Interim results of the Italian observational study (ROMEI)Massimo Breccia, Filíppo Gherlinzoni, Francesca Palandri et al.|Cancer|2025Cited by 10